Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer

BACKGROUND: Currently, no effective treatments exist for non-small cell lung cancer (NSCLC) after failure of gefitinib therapy. Pre-clinical studies have demonstrated that gefitinib-resistant NSCLC cells are more sensitive to irinotecan than parental cells, and that combined administration of irinot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Horiike, A, Kudo, K, Miyauchi, E, Ohyanagi, F, Kasahara, K, Horai, T, Nishio, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208500/
https://ncbi.nlm.nih.gov/pubmed/21915126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.375
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados